A groundbreaking study is launching to test an mRNA vaccine for norovirus, a highly contagious virus causing vomiting and diarrhea, in the UK and globally. The late-stage clinical trial will involve about 25,000 adults, primarily aged 60 and older, to assess the vaccine's effectiveness against severe illness. Norovirus leads to significant health and economic impacts, costing the world $60 billion annually. The study, part of a partnership between the UK government and Moderna, aims to advance healthcare and improve prevention strategies. Teljes cikk (Euronews.com)